Acute Cholecystitis: Comprehensive Overview
Definition
Acute cholecystitis is an acute inflammatory condition of the gallbladder, most commonly (90-95%) caused by gallstone obstruction of the cystic duct, with 5-10% being acalculous cholecystitis occurring in critically ill patients 1.
The pathophysiology involves mechanical obstruction leading to increased intraluminal pressure, gallbladder wall inflammation, and potential progression to gangrenous changes, necrosis, and perforation 2.
Classification/Types
By Etiology:
- Calculous cholecystitis (90-95%): Gallstone-related cystic duct obstruction
- Acalculous cholecystitis (5-10%): Occurs in critically ill patients without gallstones, typically associated with hypotensive episodes and prolonged gallbladder stasis 1, 2
By Severity (Tokyo Guidelines Classification):
The Tokyo Guidelines use severity grading (mild, moderate, severe) to predict outcomes and guide treatment decisions 3. This classification system helps determine whether immediate surgery or alternative approaches are appropriate.
Clinical Features
Cardinal Symptoms:
- Acute right upper quadrant pain (present in 94.1% of patients)
- Fever
- Nausea (61.0% of patients)
- Vomiting (40.1% of patients) 4
Physical Examination:
- Right upper quadrant tenderness with abdominal guarding
- Murphy's sign (though relatively insensitive - positive Murphy sign is helpful when present, but its absence does not exclude acute cholecystitis) 2, 5
- Fever
Laboratory Findings:
- Elevated white blood cell count (leukocytosis is typical, with median WBC counts ranging from 11.3-15.8 depending on imaging findings) 4
Investigations
First-Line Imaging:
Ultrasonography of the right upper quadrant is the initial diagnostic test of choice, with sensitivity of approximately 81% and specificity of approximately 83% 1.
Key Ultrasound Findings:
- Gallbladder distension
- Gallbladder wall thickening (>3mm)
- Cholelithiasis (gallstones)
- Pericholecystic fluid
- Tensile fundus sign (bulging fundus from increased intraluminal pressure)
- Intraluminal sludge in the setting of RUQ pain
- Wall hyperemia (elevated cystic or hepatic artery velocities)
- Mucosal ischemic changes (loss of mucosal echogenicity)
- Sonographic Murphy sign 2, 4
Important caveat: US is more sensitive than CT for detecting cholelithiasis (95.9%) and gallbladder wall thickening (92.3%), while CT is more sensitive for pericholecystic fluid (83.6%) and gallbladder distension (95.7%) 4.
When Ultrasound is Equivocal:
Hepatobiliary scintigraphy (HIDA scan) is the gold standard diagnostic test when ultrasound does not provide a definitive diagnosis 1. This nuclear medicine study involves intravenous injection of a radiotracer excreted in bile and has the highest diagnostic accuracy for acute cholecystitis 5.
Additional Imaging:
- CT and MRI are commonly performed to identify complications such as perforation, abscess formation, or gangrenous cholecystitis 5
Pathogenesis
The pathophysiologic sequence follows this pattern:
- Cystic duct obstruction (by gallstone or, in acalculous disease, by stasis and ischemia)
- Increased intraluminal pressure in the gallbladder
- Gallbladder wall distension and inflammation
- Vascular compromise leading to ischemia
- Potential progression to gangrenous changes, focal wall necrosis, and perforation 2
In acalculous cholecystitis specifically, the mechanism involves hypotensive episodes and prolonged gallbladder stasis leading to obstruction, ischemia, and inflammation 2.
Pathology
Macroscopic Changes:
- Gallbladder distension
- Wall thickening and edema
- Pericholecystic inflammation
- Possible gangrenous changes or perforation in advanced cases
Microscopic Changes:
- Acute inflammatory infiltrate
- Mucosal ulceration
- Wall edema and hemorrhage
- Vascular congestion
- In severe cases: transmural necrosis
Surgical Treatment
Primary Treatment Recommendation:
Early laparoscopic cholecystectomy (ELC) performed as soon as possible, within 7 days from hospital admission and within 10 days from onset of symptoms, is the treatment of choice for acute cholecystitis 3. This approach is superior to delayed surgery in terms of:
- Fewer composite postoperative complications (11.8% for early vs 34.4% for late)
- Shorter hospital stay (5.4 days vs 10.0 days)
- Lower hospital costs 1
Surgical Timing Algorithm:
Optimal timing: Perform ELC within 72 hours of diagnosis, with possible extension up to 7-10 days from symptom onset 6, 3.
If ELC cannot be performed within this window: Delayed laparoscopic cholecystectomy (DLC) should be performed beyond 6 weeks from first clinical presentation 3.
Avoid intermediate timing (7 days to 6 weeks): This "intermediate laparoscopic cholecystectomy" period is associated with worse outcomes 3.
Special Populations:
Pregnant Women:
Early laparoscopic cholecystectomy is recommended during all trimesters and is associated with lower maternal-fetal complications (1.6% for early vs 18.4% for delayed) 1.
Elderly Patients (>65 years):
Laparoscopic cholecystectomy is associated with lower 2-year mortality (15.2%) compared with nonoperative management (29.3%) 1. Surgery remains the treatment of choice even in elderly patients with comorbidities 7.
High-Risk/Critically Ill Patients:
Immediate laparoscopic cholecystectomy is superior to percutaneous transhepatic gallbladder drainage (PTGBD) even in high-risk patients 3. The CHOCOLATE trial demonstrated that patients undergoing ELC had significantly fewer major complications (5% vs 53%), with similar mortality rates but significantly less healthcare resource utilization 3.
Non-Operative Management:
Non-operative management (NOM) with antibiotics and observation should only be considered for patients refusing surgery or those truly not suitable for surgery 3. However, this approach carries significant risks:
- 30% develop recurrent gallstone-related complications (vs 3% with surgery)
- 60% eventually require surgery anyway
- High rate of gallstone-related complications (RR 6.63,95% CI 1.57-28.51) 3
Gallbladder Drainage:
Percutaneous cholecystostomy tube placement should be reserved only for patients with exceptionally high perioperative risk or those with acalculous cholecystitis who are severely ill at diagnosis 1. This is because percutaneous drainage is associated with:
- Higher postprocedural complications (65% vs 12% for laparoscopic cholecystectomy)
- Higher mortality rates
- Longer hospital stays
- More readmissions for gallstone-related diseases 3, 1
Conversion to Open Surgery:
Conversion to open surgery is not a failure but a valid safety option when laparoscopic expertise has been maximized 3. Surgeons should maintain a low threshold for conversion to ensure patient safety, particularly in difficult cases with severe inflammation or unclear anatomy.
Pre-Operative Medical Management:
Before ELC, initial management includes:
- Fasting
- Intravenous fluid resuscitation
- Antimicrobial therapy
- Analgesics as needed
- Recognition and treatment of concomitant conditions (choledocholithiasis, cholangitis, biliary pancreatitis) 6
Key Clinical Pitfalls to Avoid
Over-reliance on sonographic Murphy sign: This sign has surprisingly low sensitivity; its absence does not exclude acute cholecystitis 2.
Delaying surgery in the "intermediate period": Operating between 7 days and 6 weeks leads to worse outcomes than either early or delayed approaches 3.
Choosing percutaneous drainage over surgery in high-risk patients: Even critically ill patients benefit more from immediate laparoscopic cholecystectomy than from drainage procedures 3.
Assuming elderly or pregnant patients cannot tolerate surgery: These populations actually have better outcomes with early surgical intervention 1.
Pursuing non-operative management without understanding recurrence risk: 30% will have recurrent complications and 60% will eventually need surgery anyway 3.